Fleur Kleiburg

5PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 16, 2026
Prognostic value of baseline PSMA PET/CT for survival in synchronous metastatic hormone-sensitive prostate cancer: towards redefining low- and high-volume disease.

|Mar 27, 2025
PSMA expression and PSMA PET/CT imaging in metastatic soft tissue sarcoma patients, results of a prospective study.

F Kleiburg, T van der Hulle, H Gelderblom

|Jan 22, 2025
Baseline PSMA PET/CT parameters predict overall survival and treatment response in metastatic castration-resistant prostate cancer patients.

Fleur Kleiburg, Lioe-Fee de Geus-Oei, Romy Spijkerman

|Feb 02, 2023
Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas.

Fleur Kleiburg, Linda Heijmen, Hans Gelderblom

|Dec 23, 2022
Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer.

Floris A Vuijk, Fleur Kleiburg, Wyanne A Noortman

Pageof 1

Frequent Collaborators

1 joint publications

Floris A Vuijk

1 joint publications

Arantza Fariña-Sarasqueta

1 joint publications

Lioe-Fee de Geus-Oei